Total Payments
$1,219
2024 Payments
$380.80
Companies
19
Transactions
81
Payment Breakdown by Category
Food & Beverage$1,219 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,219 | 81 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $375.79 | 29 | $0 (2024) |
| Lilly USA, LLC | $176.22 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $129.73 | 8 | $0 (2024) |
| Dexcom, Inc. | $86.30 | 5 | $0 (2024) |
| Abbott Laboratories | $85.79 | 5 | $0 (2023) |
| Merck Sharp & Dohme LLC | $65.24 | 4 | $0 (2023) |
| Amgen Inc. | $43.22 | 3 | $0 (2024) |
| ABBVIE INC. | $35.90 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $30.75 | 2 | $0 (2024) |
| PFIZER INC. | $29.72 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $380.80 | 27 | Novo Nordisk Inc ($140.38) |
| 2023 | $552.53 | 36 | Novo Nordisk Inc ($156.86) |
| 2022 | $285.49 | 18 | Novo Nordisk Inc ($78.55) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Diabetes | ||||||
| 11/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Endocrinology | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardio-renal | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Inflammation | ||||||
| 03/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: DIABETES | ||||||
| 03/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.01 | General |
| 02/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Diabetes | ||||||
| 02/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Diabetes | ||||||
| 01/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $7.61 | General |
About Dr. Ali Mahdi, MD
Dr. Ali Mahdi, MD is a Sleep Medicine healthcare provider based in Connellsville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2018. The National Provider Identifier (NPI) number assigned to this provider is 1952887291.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Mahdi, MD has received a total of $1,219 in payments from pharmaceutical and medical device companies, with $380.80 received in 2024. These payments were reported across 81 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,219).
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Family Medicine
- Location Connellsville, PA
- Active Since 07/18/2018
- Last Updated 07/29/2022
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1952887291
Products in Payments
- Rybelsus (Drug) $161.70
- MOUNJARO (Drug) $116.94
- Ozempic (Drug) $115.34
- FARXIGA (Drug) $96.83
- Dexcom G6 Transmitter (Medical Supply) $86.30
- PROCLAIM (Device) $85.79
- EMGALITY (Drug) $44.64
- Otezla (Drug) $43.22
- ELIQUIS (Drug) $41.70
- BREZTRI (Drug) $32.90
- BELSOMRA (Drug) $30.80
- NURTEC ODT (Drug) $29.46
- TYVASO (Drug) $20.98
- GARDASIL 9 (Biological) $19.43
- Wegovy (Drug) $19.35
- QULIPTA (Drug) $18.73
- JARDIANCE (Drug) $18.45
- TRELEGY ELLIPTA (Drug) $18.00
- MINIMED 770G (Device) $17.78
- UBRELVY (Drug) $17.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.